Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maitri EnterprisesBOM:513430 +0.13%75 Pretax Margin % is 4.86% as of Mar. 2026, which is 138% above its 10-year median of 2.04. GuruFocus rates BOM:513430 with a GF Score™ of 75/100 and a GF Value™ of ₹52.30 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Maitri Enterprises ranks worse than 54.59% on this metric.
The historical rank and industry rank for Maitri Enterprises's Pretax Margin % or its related term are showing as below:
BOM:513430'
s Pretax Margin % Range Over the Past 10 Years
Min: -2.19 Med: 2.04 Max: 4.52
Current: 2.78
BOM:513430's Pretax Margin % is ranked worse than 54.59% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs BOM:513430: 2.78
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Maitri Enterprises Pretax Margin % Related Terms
Maitri Enterprises Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Maitri Enterprises's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Maitri Enterprises's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitri Enterprises Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitri Enterprises's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Maitri Enterprises's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitri Enterprises (BOM:513430) has a Pretax Margin % of 4.86% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Maitri Enterprises and its competitors. This is 138% above median its historical median of 2.04. According to the industry distribution chart, Maitri Enterprises ranks #363 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 54.6%.
Is Maitri Enterprises' Pretax Margin % too high?
Maitri Enterprises' current Pretax Margin % of 4.86% is 138% above median its 10-year median of 2.04. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. Maitri Enterprises' value of 4.86% is 20.9% above this industry median. Based on the distribution chart, Maitri Enterprises ranks #363 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Maitri Enterprises has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maitri Enterprises' Pretax Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Maitri Enterprises ranks #363 out of 665 companies for Pretax Margin %. This places Maitri Enterprises in the lower half of its industry. The industry median Pretax Margin % is 4.02. Maitri Enterprises' value of 4.86% is 20.9% above this benchmark. While the company's 10-year median is 2.04 vs. the industry median of 4.02, Maitri Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maitri Enterprises's current Pretax Margin % of 4.86% is 20.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Maitri Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitri Enterprises's current Pretax Margin % is 4.86%, which is 138% above median its own 10-year median of 2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitri Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Maitri Enterprises (BOM:513430) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹52.30, compared to a current price of ₹39.95 — trading 23.6% below its estimated fair value. The current Pretax Margin % is 4.86%, which is 138% above median its 10-year median of 2.04 and 20.9% above the Healthcare Providers & Services industry median of 4.02. Maitri Enterprises' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Maitri Enterprises (BOM:513430), the current Pretax Margin % is 4.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maitri Enterprises (BOM:513430) Overvalued in 2026?
Based on GuruFocus' analysis, Maitri Enterprises stock appears to be undervalued.
The current stock price of ₹39.95 is trading 23.6% below its estimated GF Value™ of ₹52.30.
GuruFocus considers Maitri Enterprises to be Modestly Undervalued.
Key valuation signals for BOM:513430:
Pretax Margin %: 4.86% (138% above median its 10-year median of 2.04)
GF Value™: ₹52.30 vs. price of ₹39.95 (23.6% below fair value)
Industry Position: 20.9% above the Healthcare Providers & Services median (#363 of 665)
No single metric tells the full story. See the BOM:513430 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maitri Enterprises Ltd is engaged in the trading of pharmaceutical and medical goods in India. It is also involved in the sale of services by way of a works contract. The company's operating and reporting segments are: Pharmaceutical Goods, and Infrastructure and Real Estate. The majority of its revenue is generated from the provision of work contract services.
75GF Score
Get the complete analysis for BOM:513430
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:513430 has been successfully added to your 
